✦ LIBER ✦

Chimeric L1/E2 and L1/E6 virus-like particles for the development of a therapeutic papillomavirus vaccine

✍ Scribed by Daurer, Werner; Kirnbauer, Reinhard

Book ID: 119561854
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 188 KB
Volume: 16
Category: Article
ISSN: 0923-1811
DOI: 10.1016/s0923-1811(98)83071-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human papillomavirus 16 L1–E7 chimeric v

Human papillomavirus 16 L1–E7 chimeric virus like particles show prophylactic and therapeutic efficacy in murine model of cervical cancer

✍ Chandresh Sharma; Bindu Dey; Mohammed Wahiduzzaman; Neeta Singh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1023 KB

Therapeutic vaccination of rabbits with

Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine

✍ Janet L. Brandsma; Mark Shlyankevich; Daniel Zelterman; Yuhua Su 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Immune response to human papillomavirus

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection

✍ Klaus Schäfer; Martin Müller; Stefan Faath; Annette Henn; Wolfram Osen; Hanswalt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Expression of human papillomavirus type 16 (HPV 16) fusion proteins LI deltaCE7(1-55) and LI deltaCE7(1-60) (carboxy-terminal deletion of LI replaced by 55 or 60 amino-terminal amino acids of E7) leads to formation of chimeric papillomavirus-like particles (CVLPs). After "infection" of cells by CVLP

Early assessment of the efficacy of a hu

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

✍ Darron R Brown; Kenneth H Fife; Cosette M Wheeler; Laura A Koutsky; Lisa M Lupin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Chimeric Virus-like Particles of the Hum

Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine

✍ Ingrid Jochmus; Klaus Schäfer; Stefan Faath; Martin Müller; Lutz Gissmann 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Vaccination trial with HPV16 L1E7 chimer

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

✍ Andreas M. Kaufmann; John D. Nieland; Ingrid Jochmus; Siegfried Baur; Klaus Frie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 173 KB

## Abstract Persistent infection with human papillomaviruses (HPV) is a prerequisite for the development of cervical cancer. Vaccination with virus‐like particles (VLP) has demonstrated efficacy in prophylaxis but lacks therapeutic potential. HPV16 L1E7 chimeric virus‐like particles (CVLP) consist